HK Stock MarketDetailed Quotes

CHINA NEXT-GEN (03928)

Watchlist
  • 17.380
  • -0.380-2.14%
Trading May 20 10:29 CST
8.62BMarket Cap-1580.00P/E (TTM)

CHINA NEXT-GEN (03928) Income Statement

All
YOY yoy
Hide blank lines yoy
(FY)Sep 30, 2025
(Q6)Mar 31, 2025
(FY)Sep 30, 2024
(Q6)Mar 31, 2024
(FY)Sep 30, 2023
(Q6)Mar 31, 2023
(FY)Sep 30, 2022
(Q6)Mar 31, 2022
(FY)Sep 30, 2021
(Q6)Mar 31, 2021
Turnover
10.15%61.66M
35.26%31.96M
-0.15%55.97M
-25.90%23.63M
-16.45%56.06M
3.71%31.89M
41.46%67.09M
39.11%30.74M
14.22%47.43M
-30.12%22.1M
Operating income
10.15%61.66M
35.26%31.96M
-0.15%55.97M
-25.90%23.63M
-16.45%56.06M
3.71%31.89M
41.46%67.09M
39.11%30.74M
14.22%47.43M
-30.12%22.1M
Cost of sales
-10.89%-56.75M
-39.50%-29.12M
2.06%-51.17M
30.66%-20.87M
18.20%-52.25M
0.02%-30.1M
-21.76%-63.88M
-15.78%-30.1M
-20.42%-52.46M
3.18%-26M
Operating expenses
-10.89%-56.75M
-39.50%-29.12M
2.06%-51.17M
30.66%-20.87M
18.20%-52.25M
0.02%-30.1M
-21.76%-63.88M
-15.78%-30.1M
-20.42%-52.46M
3.18%-26M
Gross profit
2.33%4.91M
3.13%2.84M
26.10%4.8M
54.16%2.75M
18.29%3.81M
178.50%1.79M
163.92%3.22M
116.45%641.34K
-146.52%-5.03M
-181.65%-3.9M
Administrative expenses
3.29%-5.8M
-3.03%-2.63M
-5.42%-6M
7.69%-2.55M
30.63%-5.69M
30.84%-2.77M
5.87%-8.2M
-1.15%-4M
-50.44%-8.71M
-41.51%-3.96M
Impairment and provision
-631.05%-1.01M
-127.98%-44.98K
114.30%189.67K
305.98%160.75K
-667.04%-1.33M
-87.79%39.6K
79.34%233.89K
508.15%324.2K
114.24%130.41K
---79.43K
-Other impairment is provision
-631.05%-1.01M
-127.98%-44.98K
114.30%189.67K
305.98%160.75K
-667.04%-1.33M
-87.79%39.6K
79.34%233.89K
508.15%324.2K
114.24%130.41K
---79.43K
Operating interest expense
----
----
----
----
----
4.92%-554.26K
4.57%-1.21M
6.79%-582.96K
-0.92%-1.27M
0.92%-625.4K
Special items of operating profit
46.05%1.66M
76.75%612.81K
-67.62%1.13M
-77.24%346.71K
-30.47%3.5M
84.65%1.52M
43.11%5.04M
-37.76%825.13K
21.00%3.52M
67.20%1.33M
Operating profit
-293.57%-240.92K
9.78%775.66K
-57.60%124.46K
2,434.40%706.57K
131.72%293.57K
101.00%27.88K
91.86%-925.44K
61.38%-2.79M
-60.10%-11.37M
-437.88%-7.23M
Financing cost
29.48%-638.79K
20.40%-361.63K
9.01%-905.89K
---454.31K
---995.64K
----
----
----
----
----
Share of profit from joint venture company
55.96%-1.2K
-20.86%-898
99.53%-2.72K
3.26%-743
-8.86%-575.14K
66.12%-768
-1,579.13%-528.33K
-287.98%-2.27K
163.86%35.72K
--1.21K
Earning before tax
-12.34%-880.91K
64.26%413.13K
38.60%-784.15K
827.72%251.52K
12.14%-1.28M
100.97%27.11K
87.17%-1.45M
61.34%-2.8M
-58.35%-11.33M
-437.83%-7.23M
Tax
----
----
----
----
710.99%240.11K
744.16%253.14K
-128.55%-39.3K
32.42%-39.3K
100.36%137.66K
86.69%-58.15K
After-tax profit from continuing operations
-12.34%-880.91K
64.26%413.13K
24.39%-784.15K
-10.25%251.52K
30.54%-1.04M
109.88%280.25K
86.66%-1.49M
61.11%-2.84M
-57.95%-11.19M
-527.84%-7.29M
Earning after tax
-12.34%-880.91K
64.26%413.13K
24.39%-784.15K
-10.25%251.52K
30.54%-1.04M
109.88%280.25K
86.66%-1.49M
61.11%-2.84M
-57.95%-11.19M
-527.84%-7.29M
Profit attributable to shareholders
-12.34%-880.91K
64.26%413.13K
24.39%-784.15K
-10.25%251.52K
30.54%-1.04M
109.88%280.25K
86.66%-1.49M
61.11%-2.84M
-57.95%-11.19M
-527.84%-7.29M
Basic earnings per share
-12.50%-0.0018
80.00%0.0009
27.27%-0.0016
-16.67%0.0005
29.03%-0.0022
110.17%0.0006
86.70%-0.0031
61.18%-0.0059
-57.43%-0.0233
-522.22%-0.0152
Diluted earnings per share
-12.50%-0.0018
80.00%0.0009
27.27%-0.0016
-16.67%0.0005
29.03%-0.0022
110.17%0.0006
86.70%-0.0031
61.18%-0.0059
-57.43%-0.0233
-522.22%-0.0152
Currency Unit
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
SGD
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Auditor
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
National Health Accounting Firm Co., Ltd.
--
(FY)Sep 30, 2025(Q6)Mar 31, 2025(FY)Sep 30, 2024(Q6)Mar 31, 2024(FY)Sep 30, 2023(Q6)Mar 31, 2023(FY)Sep 30, 2022(Q6)Mar 31, 2022(FY)Sep 30, 2021(Q6)Mar 31, 2021
Turnover 10.15%61.66M35.26%31.96M-0.15%55.97M-25.90%23.63M-16.45%56.06M3.71%31.89M41.46%67.09M39.11%30.74M14.22%47.43M-30.12%22.1M
Operating income 10.15%61.66M35.26%31.96M-0.15%55.97M-25.90%23.63M-16.45%56.06M3.71%31.89M41.46%67.09M39.11%30.74M14.22%47.43M-30.12%22.1M
Cost of sales -10.89%-56.75M-39.50%-29.12M2.06%-51.17M30.66%-20.87M18.20%-52.25M0.02%-30.1M-21.76%-63.88M-15.78%-30.1M-20.42%-52.46M3.18%-26M
Operating expenses -10.89%-56.75M-39.50%-29.12M2.06%-51.17M30.66%-20.87M18.20%-52.25M0.02%-30.1M-21.76%-63.88M-15.78%-30.1M-20.42%-52.46M3.18%-26M
Gross profit 2.33%4.91M3.13%2.84M26.10%4.8M54.16%2.75M18.29%3.81M178.50%1.79M163.92%3.22M116.45%641.34K-146.52%-5.03M-181.65%-3.9M
Administrative expenses 3.29%-5.8M-3.03%-2.63M-5.42%-6M7.69%-2.55M30.63%-5.69M30.84%-2.77M5.87%-8.2M-1.15%-4M-50.44%-8.71M-41.51%-3.96M
Impairment and provision -631.05%-1.01M-127.98%-44.98K114.30%189.67K305.98%160.75K-667.04%-1.33M-87.79%39.6K79.34%233.89K508.15%324.2K114.24%130.41K---79.43K
-Other impairment is provision -631.05%-1.01M-127.98%-44.98K114.30%189.67K305.98%160.75K-667.04%-1.33M-87.79%39.6K79.34%233.89K508.15%324.2K114.24%130.41K---79.43K
Operating interest expense --------------------4.92%-554.26K4.57%-1.21M6.79%-582.96K-0.92%-1.27M0.92%-625.4K
Special items of operating profit 46.05%1.66M76.75%612.81K-67.62%1.13M-77.24%346.71K-30.47%3.5M84.65%1.52M43.11%5.04M-37.76%825.13K21.00%3.52M67.20%1.33M
Operating profit -293.57%-240.92K9.78%775.66K-57.60%124.46K2,434.40%706.57K131.72%293.57K101.00%27.88K91.86%-925.44K61.38%-2.79M-60.10%-11.37M-437.88%-7.23M
Financing cost 29.48%-638.79K20.40%-361.63K9.01%-905.89K---454.31K---995.64K--------------------
Share of profit from joint venture company 55.96%-1.2K-20.86%-89899.53%-2.72K3.26%-743-8.86%-575.14K66.12%-768-1,579.13%-528.33K-287.98%-2.27K163.86%35.72K--1.21K
Earning before tax -12.34%-880.91K64.26%413.13K38.60%-784.15K827.72%251.52K12.14%-1.28M100.97%27.11K87.17%-1.45M61.34%-2.8M-58.35%-11.33M-437.83%-7.23M
Tax ----------------710.99%240.11K744.16%253.14K-128.55%-39.3K32.42%-39.3K100.36%137.66K86.69%-58.15K
After-tax profit from continuing operations -12.34%-880.91K64.26%413.13K24.39%-784.15K-10.25%251.52K30.54%-1.04M109.88%280.25K86.66%-1.49M61.11%-2.84M-57.95%-11.19M-527.84%-7.29M
Earning after tax -12.34%-880.91K64.26%413.13K24.39%-784.15K-10.25%251.52K30.54%-1.04M109.88%280.25K86.66%-1.49M61.11%-2.84M-57.95%-11.19M-527.84%-7.29M
Profit attributable to shareholders -12.34%-880.91K64.26%413.13K24.39%-784.15K-10.25%251.52K30.54%-1.04M109.88%280.25K86.66%-1.49M61.11%-2.84M-57.95%-11.19M-527.84%-7.29M
Basic earnings per share -12.50%-0.001880.00%0.000927.27%-0.0016-16.67%0.000529.03%-0.0022110.17%0.000686.70%-0.003161.18%-0.0059-57.43%-0.0233-522.22%-0.0152
Diluted earnings per share -12.50%-0.001880.00%0.000927.27%-0.0016-16.67%0.000529.03%-0.0022110.17%0.000686.70%-0.003161.18%-0.0059-57.43%-0.0233-522.22%-0.0152
Currency Unit SGDSGDSGDSGDSGDSGDSGDSGDSGDSGD
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--
Auditor National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--National Health Accounting Firm Co., Ltd.--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
China and the US begin implementing the Kuala Lumpur economic and trade consultation consensus.
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More